Van Hulzen Asset Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,018
Closed -$514K 302
2020
Q4
$514K Buy
16,018
+1,653
+12% +$50.9K 0.08% 139
2020
Q3
$454K Buy
+14,365
New +$475K 0.07% 138
2020
Q2
Sell
-13,975
Closed -$402K 282
2020
Q1
$402K Sell
13,975
-1,849
-12% -$48.5K 0.09% 137
2019
Q4
$372K Sell
15,824
-1,301
-8% -$29.1K 0.07% 191
2019
Q3
$309K Sell
17,125
-21,129
-55% -$349K 0.07% 202
2019
Q2
$599K Buy
38,254
+4,235
+12% +$83.3K 0.13% 114
2019
Q1
$775K Buy
34,019
+14,303
+73% +$322K 0.21% 85
2018
Q4
$459K Buy
19,716
+11,736
+147% +$313K 0.13% 115
2018
Q3
$263K Buy
7,980
+935
+13% +$34.9K 0.07% 188
2018
Q2
$310K Buy
+7,045
New +$273K 0.09% 138

Other funds holding PETS

Van Hulzen Asset Management's PETS Position: Q1 2021 in Review

Van Hulzen Asset Management sold out of PetMed Express (PETS) in Q1 2021, closing a stake of 16,018 shares — an estimated $514K sold.

Van Hulzen Asset Management first reported a position in PETS in Q2 2018 and held it in 10 quarters. The position peaked at $775K in Q1 2019. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2021.

  • Van Hulzen Asset Management reported no remaining PetMed Express position as of Q1 2021 after selling out during the quarter.
  • Van Hulzen Asset Management sold 16,018 PetMed Express shares in Q1 2021, an estimated $514K.
  • Van Hulzen Asset Management first reported a position in PetMed Express in Q2 2018 and held it in 10 quarters.
  • Van Hulzen Asset Management's PetMed Express position peaked at $775K in Q1 2019.
  • 205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2021.

Based on Van Hulzen Asset Management's 13F filing for Q1 2021, filed 12 May 2021.